Skip to main content
# Title Department Research Year
311 Betaxolol‐loaded Niosomes Integrated Within pH‐sensitive in situ Forming
Gel for Management of Glaucoma
Department of Pharmaceutics 2021
312 Preclinical validation of a novel oral Edaravone formulation for treatment of frontotemporal dementia 2021
313 One pot fabrication of fluorescein functionalized manganese dioxide for fluorescence “Turn OFF–ON” sensing of hydrogen peroxide in water and cosmetic samples Department of Pharmaceutical Analytical Chemistry 2020
314 Chemical Composition and Biological Activity of Capetula and Shoots Essential Oils of Senecio
glaucus L.
2020
315 Combining acetyl salicylic acid and rofecoxib into novel oral tablets normalize platelet function with potential higher tolerability in patients with cardiovascular disorders Department of Pharmaceutical Analytical Chemistry 2020
316 Latanoprost niosomes as a sustained release ocular delivery system for the
management of glaucoma
Department of Pharmaceutics 2020
317 Development of Near-Infrared Fluorescent Probes with Large Stokes Shifts for Non-Invasive Imaging of Tumor Hypoxia Department of Pharmaceutical Organic Chemistry 2020
318 Nanomedicine as a promising approach for diagnosis, treatment and prophylaxis against COVID-19 2020
319 TLC-spectrodensitometric method for simultaneous determination of dapagliflozin and rosuvastatin in rabbit plasma: stability indicating assay and kinetic studies Department of Pharmaceutical Analytical Chemistry 2020
320 Severe cutaneous adverse drug reactions: Incidence, Clinical Patterns, Causative Drugs and Modalities of Treatment in Assiut University Hospital, Upper Egypt Department of Clinical Pharmacy 2020